Benzyl Alcohol 0.9% (3ml & 10ml)

Benzyl Alcohol 0.9% is a sterile aqueous solution used as a bacteriostatic preservative in peptide reconstitution, formulated and packaged in the USA under controlled conditions. Each batch is sterile-filtered and verified for concentration and pH, with independent third-party quality testing confirming compliance. For laboratory research use only.

Each batch of Benzyl Alcohol 0.9% (3ml & 10ml) is checked for specification compliance to support dependable research workflows.

Benzyl Alcohol 0.9% (3ml & 10ml) is supplied as a laboratory accessory for peptide reconstitution, storage, and handling research workflows.

Research facilities use Benzyl Alcohol 0.9% (3ml & 10ml) alongside peptide vials to standardize reconstitution and preparation protocols.

This product is available in 3ml and 10ml. Each vial contains lyophilized peptide at the labeled quantity; wholesale orders are packed in boxes of ten vials at a single per-vial price.

Quality assurance: every batch is purified by reversed-phase high-performance liquid chromatography and identity-confirmed by mass spectrometry, with purity above 99%. Lot-specific certificates of analysis are available on request. Store lyophilized vials at -20°C, protected from light and moisture; reconstitute with bacteriostatic water immediately before use and avoid repeated freeze-thaw cycles. For in-vitro laboratory research use only — not for human or veterinary use.

Research & Literature

The following peer-reviewed studies and reference documents are commonly consulted by researchers working with Benzyl Alcohol 0.9% (3ml & 10ml). Summaries are provided for orientation only and reflect the cited sources.

PubChem Compound Summary for CID 244, Benzyl alcohol^[1] — This PubChem record catalogs the chemical identity of benzyl alcohol (CID 244), including its molecular formula, structure, and physicochemical properties. It also compiles information on its uses, safety, and regulatory status as an antimicrobial preservative and pharmaceutical solvent. (PubChem 2026)

Antimicrobial Preservative Use in Parenteral Products: Past and Present^[2] — This review documented the historical use of benzyl alcohol as an antimicrobial preservative in parenteral formulations and assessed its current regulatory standing. It discussed the efficacy and safety considerations that shape its use in multidose injectable products. The authors provided a perspective on how preservative practice in pharmaceutical manufacturing has evolved over time. (Journal of Pharmaceutical Sciences 2007)

Benzyl alcohol: toxic agent in neonatal units^[3] — This report described a toxicity syndrome associated with benzyl alcohol exposure in neonates, linked to its presence in saline flush solutions at the time. The findings informed safe concentration limits and cautionary practices for benzyl alcohol in pharmaceutical products. It remains a foundational safety reference for this preservative. (Pediatrics 1983)

References

1. National Center for Biotechnology Information. "PubChem Compound Summary for CID 244, Benzyl alcohol." PubChem. 2026. pubchem.ncbi.nlm.nih.gov/compound/244
2. Meyer BK, Ni A, Hu B, Shi L. "Antimicrobial Preservative Use in Parenteral Products: Past and Present." Journal of Pharmaceutical Sciences. 2007. pubmed.ncbi.nlm.nih.gov/17722087/
3. Kauffman RE. "Benzyl alcohol: toxic agent in neonatal units." Pediatrics. 1983. www.semanticscholar.org/paper/Benzyl-alcohol-toxic-agent-in-neonatal-…

All products are supplied as lyophilized powder for in-vitro laboratory research use only and are not for human or veterinary use.